"The fact that he chose to disclose that, after probably being inundated by shareholder queries, indicates his confidence that the data will prove to be meaningful."
Bullshit.
He cherry picked one bit of data that appears to be favorable and ignored the rest.
If he wanted to indicate his confidence in the drug and its results, then he would have waited until the trial finished and then published the results in a balanced PR, with appropriate data and statistics, followed in due course by publication in a peer-reviewed journal, or if the results were that spectacular by a "breaking news" presentation at the next available scientific/clinical proper meeting such as ASCO, ICAAC or ICC.
This absurd grand-standing PR smacks of attempted manipulation to drum up some volume, but in reality is a mean-spirited attack on cancer sufferers and their families.
Anyone associated with today's puff PR should be thoroughly ashamed of themselves, partly for their wilful disregard for GCP, but mainly because of the harm they've done to the patients they say they're trying to help.
"It is difficult to get a man to understand something, when his salary depends upon his not understanding it."
Upton Sinclair
"Nobody ever went broke underestimating the intelligence of the American public."
H. L. Mencken
AI
